V. C. G. Tjan-Heijnen
University Medical Center Nijmegen
Department of Medical Oncology
Netherlands
Name/email consistency: high
- An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn. Tjan-Heijnen, V.C., Wagener, D.J., Postmus, P.E. Ann. Oncol. (2002)
- Consensus conference on palliative treatment of stage IV non-small cell lung cancer. Consensus meeting of the Netherlands Society for Medical Oncology and the Taskforce on Lung Cancer of the Dutch Society of Physicians for Lung Diseases and Tuberculosis. Tjan-Heijnen, V.C., Groen, H.J., Schramel, F.M., Stoter, G. Neth. J. Med (2001)
- Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study. Tjan-Heijnen, V.C., Postmus, P.E., Ardizzoni, A., Manegold, C.H., Burghouts, J., van Meerbeeck, J., Gans, S., Mollers, M., Buchholz, E., Biesma, B., Legrand, C., Debruyne, C., Giaccone, G. Ann. Oncol. (2001)
- Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Tjan-Heijnen, V.C., Buit, P., de Widt-Evert, L.M., Ruers, T.J., Beex, L.V. Breast Cancer Res. Treat. (2001)
- Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma. Tjan-Heijnen, V.C., Biesma, B., Festen, J., Splinter, T.A., Cox, A., Wagener, D.J., Postmus, P.E. J. Clin. Oncol. (1998)